Trials / Completed
CompletedNCT00781092
A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Durrie Vision · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to compare two post operative drop regimens for the management of dry eye and control of healing using FDA-approved ophthalmic solutions.
Detailed description
This comparison will be made between bilateral eyes of the same patient following excimer laser ablation using the FDA-approved LADARVision 4000 Excimer Laser System or the WaveLight ALLEGRETTO WAVE™ Excimer Laser System. Post operative questionnaires regarding the use of the drops will be compared. Tear osmolarity and tear breakup time will be evaluated using Tear Lab and OQAS II.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Systane Ultra | Ophthalmic Solution, 1 gtt, three times daily to both eyes for 1 month post operative |
| OTHER | Bausch and Lomb Sensitive Eyes | Ophthalmic Solution, 1 gtt, three times a day in both eyes for 1 month after LASIK |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2008-10-28
- Last updated
- 2012-09-20
Source: ClinicalTrials.gov record NCT00781092. Inclusion in this directory is not an endorsement.